Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 111,156 shares at $46.01 ($5.1M) on 2025-09-05, disclosed to the SEC on 2025-09-08.
Scheduled sale ($5.1M) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.01 | 55,578 | $2.6M | 50.0% |
| 2 | $46.01 | 55,578 | $2.6M | 50.0% |
| Total | $46.01 avg | 111,156 | $5.1M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |